Ontology highlight
ABSTRACT: Introduction
Circulating levels of the antiangiogenic protein vasoinhibin, a fragment of prolactin, are of interest in vasoproliferative retinopathies, preeclampsia, and peripartum cardiomyopathy; however, it is difficult to determine the circulating levels of vasoinhibin due to the lack of quantitative assays.Methods
This study used human serum samples to assess the concentration and bioactivity of vasoinhibin using a novel enzyme-linked immunosorbent assay (ELISA) for human vasoinhibin, which employs an anti-vasoinhibin monoclonal antibody, a human umbilical vein endothelial cell (HUVEC) proliferation assay, and a chick chorioallantoic membrane (CAM) angiogenesis assay.Results
Serum samples from 17 pregnant women without (one group) and with preeclampsia and pregn
SUBMITTER: Zamora M
PROVIDER: S-EPMC11089174 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature